On the other hand, it has been suggested that overexpression of ACE2 can be a risk factor for COVID-19 exacerbation due to the observation that the elderly population receives drug prescriptions that increase the expression of ACE2 and therefore has a higher risk of developing severe COVID-19. Here, ACE2 is linked to COVID-19.